Close Menu

NEW YORK (GenomeWeb) – Microbial genetics analysis firm OpGen filed a prospectus on Tuesday for an initial public offering to raise up to about $37 million. 

The Gaithersburg, Md.-based company has not priced its shares yet or said how many shares it plans to offer. It intends to list on the Nasdaq Capital Market under ticker symbol "OPGN." The Maxim Group is listed on OpGen's Form S-1 filed with the US Securities and Exchange Commission as the underwriter for the offering. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

In Nature this week: the largest known collection of human genetic variants, and more.